105 CMR 300.00 — Reportable diseases, surveillance, and isolation and quarantine requirements

105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 300.000:REPORTABLE DISEASES, SURVEILLANCE, AND ISOLATION AND QUARANTINE REQUIREMENTS Section

105 CMR 300.00 Reportable diseases, surveillance, and isolation and quarantine requirements

300.001 Purpose

300.001: Purpose

300.020 Definitions

300.020: Definitions

300.050 Disease Surveillance and Case Management System

300.050: Disease Surveillance and Case Management System

300.100 Diseases Reportable to Local Boards of Health

300.100: Diseases Reportable to Local Boards of Health

300.110 Case Reports by Local Boards of Health

300.110: Case Reports by Local Boards of Health

300.120 Confidentiality

300.120: Confidentiality

300.131 Illness Believed to Be Due to Food Consumption

300.131: Illness Believed to Be Due to Food Consumption

300.132 Illness Believed to Be Transmissible Through Food

300.132: Illness Believed to Be Transmissible Through Food

300.133 Illness Believed to Be Unusual

300.133: Illness Believed to Be Unusual

300.134 Illness Believed to Be Part of a Suspected or Confirmed Cluster or Outbreak

300.134: Illness Believed to Be Part of a Suspected or Confirmed Cluster or Outbreak

300.135 Reporting of Pediatric Influenza Deaths, Severe and Unusual Illness Due to Influenza, Cases

300.135: Reporting of Pediatric Influenza Deaths, Severe and Unusual Illness Due to Influenza, Cases of Antiviral Treatment or Prophylaxis Failure, and Illness Believed to Be Due to Novel Influenza Viruses

300.136 Reporting of Infection or Suspected Infection Believed to Be Transmitted by a Transfused Blood

300.136: Reporting of Infection or Suspected Infection Believed to Be Transmitted by a Transfused Blood Product or Transplanted Organ, Tissue or Tissue Product

300.140 Reporting of Animal Diseases with Zoonotic Potential by Veterinarians

300.140: Reporting of Animal Diseases with Zoonotic Potential by Veterinarians

300.150 Declaring a Disease or Condition Immediately Reportable, under Surveillance and/or Subject to

300.150: Declaring a Disease or Condition Immediately Reportable, under Surveillance and/or Subject to Isolation and Quarantine: Temporary Reporting, Surveillance and/or Isolation and Quarantine

300.160 Diseases Reportable by Local Boards of Health to the Department

300.160: Diseases Reportable by Local Boards of Health to the Department

300.170 Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by

300.170: Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Laboratories

300.171 Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility

300.171: Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test Results (Antibiograms)

300.172 Submission of Selected Isolates and Diagnostic Specimens to the State Public Health Laboratory

300.172: Submission of Selected Isolates and Diagnostic Specimens to the State Public Health Laboratory

300.173 Reporting of Certain Negative and Indeterminant Diagnostic Tests Associated with

300.173: Reporting of Certain Negative and Indeterminant Diagnostic Tests Associated with Ascertainment of Infection Status

300.174 Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department

300.174: Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Point of Care Testing

300.175 Potential Exposures to Certain Infectious Agents in Clinical Laboratories and Research Settings

300.175: Potential Exposures to Certain Infectious Agents in Clinical Laboratories and Research Settings Reportable Directly to the Department

300.180 Diseases Reportable Directly to the Department

300.180: Diseases Reportable Directly to the Department

300.181 Reporting Work-related Disease Outbreaks

300.181: Reporting Work-related Disease Outbreaks

300.182 Joint Authority with Department of Labor and Workforce Development

300.182: Joint Authority with Department of Labor and Workforce Development

300.190 Surveillance and Control of Diseases Dangerous to the Public Health

300.190: Surveillance and Control of Diseases Dangerous to the Public Health

300.191 Access to Medical Records and Other Information

300.191: Access to Medical Records and Other Information

300.192 Surveillance of Diseases Possibly Linked to Environmental Exposures

300.192: Surveillance of Diseases Possibly Linked to Environmental Exposures

300.193 Surveillance of Injuries Dangerous to Public Health

300.193: Surveillance of Injuries Dangerous to Public Health

300.200 Isolation and Quarantine Requirements

300.200: Isolation and Quarantine Requirements

300.210 Procedures for Isolation and Quarantine

300.210: Procedures for Isolation and Quarantine

300.001 Purpose

300.001: Purpose The purpose of 105 CMR 300.000 is to list diseases dangerous to the public health as designated by the Department of Public Health and to establish reporting, surveillance, isolation and quarantine requirements. 105 CMR 300.000 is intended for application by local boards of health, hospitals, laboratories, physicians and other health care workers, veterinarians, education officials, recreational program health service providers, food industry officials, and the public.

300.020 Definitions

300.020: Definitions Airborne Precautions. Measures designed to reduce the risk of transmission of infectious agents that may be suspended in the air in either small particle aerosols or dust particles (i.e. droplet nuclei <= 5 microns). Patients in health care facilities must be given a private room with special air handling and ventilation (negative pressure with respect to the rest of the facility), and an appropriate level of respiratory protection is necessary when entering the patient’s room. (Mass. Register #1470 5/27/22)

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.020 continued

300.020: continued Board of Health or Local Board of Health. The appropriate and legally designated health authority of the city, town, or other legally constituted governmental unit within the Commonwealth having the usual powers and duties of the board of health or health department of a city or town. Carrier. An individual who can tolerate an infection so as not to become ill, yet is able to transmit the disease-causing organism to cause infection and illness in others. Case or Patient. One who is ill, infected, injured or diagnosed with a reportable disease or injury. Clinical Data. Health observations collected as part of an investigation of an individual or population used to inform understanding of or describe a particular disease, disease event or illness. Cluster. See 105 CMR 300.020: Outbreak or Cluster. Communicable. Ability of an infection to be transmitted from one person or animal to another. Contact. A person who has been in such association with an infected person or animal or with a contaminated environment as to have had exposure capable of transmitting the infection to that person. Contact Precautions. Measures designed to reduce the risk of transmission of infectious agents that can be spread through direct contact with the patient or indirect contact with potentially infectious items or surfaces. Gloves and gowns are required for all patient contact and contact with the patient’s environment; strict hand hygiene practices must also be applied. Counseling. Process by which individuals and groups are advised as to how to promote, maintain and/or restore health. Methods and procedures used in counseling must take account of the ways in which people develop various forms of behavior, of the factors that lead them to maintain or to alter their behavior, and of the ways in which people acquire and use knowledge. Date of Last Exposure. That point in time when exposure that would be expected to provide an opportunity for transmission of infection between a case or carrier and a susceptible person ends, or point in time when a case or carrier is no longer capable of transmitting illness or infection to others, whichever was more recent. Demographic Data. Characteristics or attributes of individuals used to inform understanding of particular disease, disease event or illness by describing the population affected. Demographic data includes age, gender, sexual orientation, race, ethnicity, disability, occupation, preferred language, and any other demographic data element as defined by the Department. Department. The Massachusetts Department of Public Health. Disease. An abnormal condition or functional impairment resulting from infection, metabolic abnormalities, physical or physiological injury or other cause, marked by subjective complaints, associated with a specific history, and clinical signs and symptoms, and/or laboratory or radiographic findings (compare 105 CMR 300.020: Illness). Disease Event. An occurrence of a reportable disease or laboratory evidence of infection reported to a board of health or the Department and entered into the disease surveillance and case management system, MAVEN. Disease Surveillance and Case Management System. The secure electronic system maintained by the Department to receive reports of disease events; collect clinical data, demographic data, epidemiologic data; conduct surveillance of disease; investigation, response, and control of diseases dangerous to the public health. Droplet Precautions. Measures designed to reduce the risk of transmission of infectious agents via large particle droplets that do not remain suspended in air, usually generated by coughing, sneezing or talking. Masks must be used, but gowns, gloves and special air handling are not generally needed.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.020 continued

300.020: continued Enteric Precautions. Measures designed to prevent direct or indirect fecal-oral transmission of disease. Gowns must be worn if soiling is likely, and gloves must be worn for touching contaminated materials; strict hand hygiene practices must also be applied. Masks are not indicated. Epidemiologic Data. Observations collected as part of an investigation in an individual or population used to inform understanding and the distribution of a particular disease, disease event or illness. Exposure. Proximity to, and or contact with, a source of an infectious agent with potential for acquisition of the infection. Food. Any raw, cooked or processed edible substance, ice, beverage, medications, or ingredient used or intended for use or for sale in whole or in part for human consumption via the alimentary tract. Food Handler. Any person directly preparing or handling food. This could include the food handling facility owner, individual having supervisory or management duties, person on the payroll, family member, volunteer, person performing work under contractual agreement, or any other person working in a food handling facility. Food Handler also includes any person handling clean dishes or utensils. Any person who dispenses medications by hand, assists in feeding, or provides mouth care shall be considered food handlers for the purpose of 105 CMR 300.000. In health care facilities, this includes those who set up trays for patients to eat, feed or assist patients in eating, give oral medications or give mouth/denture care. In day care facilities, schools and community residential programs, this includes those who prepare food for clients to eat, feed or assist clients in eating, or give oral medications. Food Handler does not include individuals in private homes preparing or serving food for individual family consumption. Food Handling Facility. Any fixed or mobile place, structure or vehicle, whether permanent, seasonal or temporary, in which food is prepared, processed, stored or held for sale, whether at retail or wholesale, or for service on the premises or elsewhere; or where food is served or provided to the public or segment of the public with or without charge. Food Handling Facility does not include private homes where food is prepared or served for individual family consumption. Food Poisoning. Poisoning that results from eating foods contaminated with toxins. These toxins may occur naturally, as in certain mushrooms or seafoods; they may be chemical or biologic contaminants; or they may be metabolic products of infectious agents that are present in the food. Health Care Provider. As defined in M.G.L. c. 111, § 1: "... any doctor of medicine, osteopathy, or dental science, or a registered nurse, registered pharmacist, social worker, doctor of chiropractic, or psychologist licensed under the provisions of M.G.L. c. 112, or an intern, or a resident, fellow, or medical officer licensed under M.G.L. c. 112, § 9, or a hospital, clinic or nursing home licensed under the provisions of M.G.L. c. 111 and its agents and employees, or a public hospital and its agents and employees;" Health Care Worker. One who provides direct care to patients or who works in a setting where such care is provided. Hepatitis Syndrome, Acute. Illness associated with symptoms, including but not limited to, jaundice, nausea, vomiting, abdominal pain, and laboratory evidence of liver damage or dysfunction occurring without identified cause or due to an unexpected or unusual cause. Illness. An abnormal condition or functional impairment resulting from infection, metabolic abnormalities, physical or physiological injury or other cause, marked by subjective complaints and clinical signs (compare 105 CMR 300.020: Disease).

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.020 continued

300.020: continued Immunity. Possession of protective antibodies or cellular components sufficient to protect from infection and/or illness following exposure to an infectious agent (see also 105 CMR

300.020 Resistance).

300.020: Resistance). Incidence. A general term used to characterize the frequency of new occurrences of a disease, infection, or other event over a period of time and in relation to the population in which it occurs. Incidence is expressed as a rate, commonly the number of new cases during a prescribed time in a unit of population. For example, one may refer to the number of new cases of tuberculosis per 100,000 population per year. Invasive Infection. Infection involving the bloodstream or internal organs, not including infection of the skin or mucous membranes. Invasive infection is usually established by the recovery of an etiologic agent from a usually sterile body fluid or tissue. Isolation. Separation, for the period of communicability, of infected persons from others in such places and under such conditions as will prevent the direct or indirect transmission of an infectious agent to susceptible people or to those who may spread the agent to others. Isolation applies also to animals (compare 105 CMR 300.020: Quarantine). Laboratory. As defined in M.G.L. c. 111D, § 1 "... a facility or place, however named, the purpose of which is to make biological, serological, chemical, immuno-hematological, cytological, pathological, or other examinations of materials derived from a human body. This includes laboratories in hospitals and other facilities. Laboratory Data. Characteristics or attributes associated with biological serological, chemical, immune-hematological, cytological, pathological, or other examinations of materials. MAVEN. The Massachusetts Virtual Epidemiologic Network, the Department's infectious disease surveillance and case management system. Novel Influenza A Viruses. A strain of influenza A that substantially differs antigenically from circulating or recently circulating influenza A viruses. Outbreak or Cluster. The occurrence in a community, facility, workplace or region of cases of an illness clearly in excess of the number of cases usually expected. The number of cases indicating an outbreak or cluster will vary according to the infectious agent or the site conditions/hazards, size and type of population exposed, previous experience or lack of exposure to the disease, and time and place of occurrence. Outbreaks or clusters are therefore identified by significant increases in the usual frequency of the disease in the same area, among the specified population, at the same season of the year. Point of Care Testing. Testing done at or near the site of patient care by use of a test cleared by the federal Food and Drug Administration for such use. Prophylaxis. The administration of a drug or biologic agent to prevent the development of an infection or disease, or limit the progression of an infection. Quarantine. Restricting the freedom of movement of well persons or domestic animals who have been exposed to a communicable disease for a period of time relating to the usual incubation period of the disease, in order to prevent effective contact with those not so exposed (compare

300.020 Isolation).

105 CMR 300.020: Isolation). Report of a Disease. A notice submitted pursuant to reporting requirements in 105 CMR 300.000 that shall include contact information for the clinician responsible for reporting the disease and full personal demographic, clinical, epidemiologic and laboratory information on the case, to the appropriate authority of the occurrence of a specified disease in people or animals, directly by telephone, in writing, by facsimile, or by electronic means. Content of reports to the Department shall be defined on a disease by disease basis. Also see 105 CMR 300.170 for laboratory reports.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.020 continued

300.020: continued Resistance. The sum total of body mechanisms which interpose barriers to the progress of invasion or multiplication of infectious agents or to damage by their toxic products. (1) Immunity is that resistance usually associated with possessing antibodies or cells having a specific activity against the etiologic agent of an infectious disease. Passive immunity is attained either naturally by maternal transfer or artificially by introducing specific protective antibodies. Passive immunity is of brief duration. Active immunity is attained by infection, with or without symptoms, or by introducing certain fractions or products of the infectious agent or the agent itself in a killed, modified or variant form. (2) Natural resistance is the ability to resist disease independently of antibodies or a specific cellular response. It commonly rests in anatomic, cellular or physiologic characteristics of the host. It may be genetic or acquired, permanent or temporary. Respiratory Hygiene/Cough Etiquette. Measures to prevent the transmission of all respiratory infections, that includes covering of the nose/mouth when coughing or sneezing, use and safe disposal of tissues and hand hygiene. Risk. The probability of an individual developing a given disease or experiencing a change in health status over a specific period of time. Self-monitoring. The practice of an individual observing their own clinical presentation to promote prompt recognition of infection or illness. This may include documentation of the observation by public health authorities. Spinal Cord Injury. The occurrence of an acute traumatic lesion of neural elements in the spinal canal (spinal cord or cauda equina) resulting in temporary or permanent sensory deficit, motor deficit, or bowel or bladder dysfunction. Standard Precautions. Refers to consistent and prudent preventive measures to be used at all times regardless of patient’s infection status. The Department adopts, by reference, as standard precautions for infection control, the 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, published by the U.S. Centers for Disease Control and Prevention and its Healthcare Infection Control Practices Advisory Committee. Surveillance of Disease. Monitoring the occurrence and spread of disease and indications of such occurrence and spread. Susceptible. A person or animal not possessing resistance to a pathogenic agent. Such a person or animal is liable to contract a disease if or when significantly exposed to such agent. Suspect Case. A person or animal with clinical and/or laboratory evidence suggestive of the existence of a disease or condition dangerous to the public health, but prior to the confirmation of such a diagnosis. Traumatic Amputation. An unintentional severing of some or all of a body part. Traumatic Brain Injury. An occurrence of injury to the head, arising from blunt or penetrating trauma or from acceleration-deceleration forces, with one or more of the following conditions attributed to the injury: decreased level of consciousness, amnesia, skull fracture, or objective evidence of a neurological or neuropsychological abnormality or diagnosed intracranial lesion. Tuberculosis. (1) Active Tuberculosis. A disease that is caused by Mycobacterium tuberculosis or other members of the Mycobacterium tuberculosis complex family in any part of the body and that is in active state as determined by either: (a) a positive diagnostic test for tuberculosis on any human specimen and the person has not completed the appropriate prescribed course of medication for active tuberculosis disease; (b) radiographic, current clinical, or laboratory evidence sufficient to support a clinical diagnosis of tuberculosis for which treatment is indicated.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.020 continued

300.020: continued (2) Tuberculosis Infection (also known as Latent Tuberculosis Infection). Condition in which living tubercle bacilli are present in an individual, without producing clinically active disease. Infected individuals usually have a positive tuberculin skin test or laboratory test for tuberculosis infection (such as an interferon release assay or IGRA), but are not infectious. Unusual Disease. A disease, by any indication, occurring for the first time, or rarely, in a geographic area or circumstance, or associated with signs and symptoms not otherwise expected to occur based on the known or presumed etiology of the disease. Unusual Illness. An illness, by any indication, occurring for the first time, or rarely in a geographic area or circumstance, or an illness associated with signs and symptoms not otherwise expected to occur based on the known or presumed etiology of the illness. Work-related Disease. A disease or condition which is believed to be caused or aggravated by conditions in the individual’s workplace. Work-related Serious Traumatic Injury to a Person Younger than 18 Years Old. An injury to a person younger than 18 years old which: (1) results in death, hospitalization, or, in the judgment of the treating physician, results in significant scarring or disfigurement, permanent disability, significant loss of consciousness, or loss of a body part or bodily function; or which (2) the physician determines is less significant but is of the same or similar nature to injuries previously sustained at the same place of employment. Zoonotic. Infectious disease of animals that can be transmitted to humans.

300.050 Disease Surveillance and Case Management System

300.050: Disease Surveillance and Case Management System The Department shall maintain MAVEN to: receive reports of disease events; collect clinical, demographic and epidemiologic data; conduct surveillance (also known as monitoring) for diseases; conduct investigations; respond to and control diseases dangerous to the public health. Local boards of health shall have MAVEN access for these purposes according to their jurisdiction. Where necessary for the investigation, monitoring, control or prevention of diseases dangerous to the public health, the Department may designate other individuals as able to access MAVEN. Access so designated by the Department shall be strictly limited to such necessity.

300.100 Diseases Reportable to Local Boards of Health

300.100: Diseases Reportable to Local Boards of Health Cases or suspect cases of the diseases listed below shall be reported by household members, physicians and other health care providers as defined by M.G.L. c. 111, § 1, and other officials designated by the Department, by telephone, in writing, by facsimile or other secure electronic means, as deemed acceptable by the Department, including transmission from electronic health records, immediately, but in no case more than 24 hours after diagnosis or identification, to the board of health in the community where the case is diagnosed or suspect case is identified. Full demographic, clinical and epidemiologic information, as defined by the Department, must be included for each report. The local board of health's responsibility, upon receipt of a report, is set forth in 105 CMR 300.110 and 300.160. Physicians and other health care providers shall also report the diseases listed below when identified to be present through point of care testing. If diseases primarily ascertained through laboratory testing are reported to the Department pursuant to 105 CMR 300.170 through 300.174, such report may serve in lieu of direct reporting to local boards of health: Amebiasis Anaplasmosis Anthrax Arbovirus infection including, but not limited to, infection caused by: chikungunya virus, dengue, eastern equine encephalitis virus, Jamestown Canyon virus, West Nile virus, yellow fever virus, and Zika virus

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.100 continued

300.100: continued Babesiosis Botulism Brucellosis Campylobacteriosis Cholera COVID-19 Creutzfeldt-Jakob disease or variant Creutzfeld-Jakob disease Cryptosporidiosis Cyclosporiasis Diphtheria Ehrlichiosis Encephalitis, any cause Foodborne illness due to toxins (including mushroom toxins, ciguatera toxins, scombrotoxin, tetrodotoxin, paralytic shellfish toxin and amnesic shellfish toxin, staphylococcus enterotoxin, and others) Giardiasis Glanders Group A streptococcus, invasive infection Group B streptococcus, invasive infection in children younger than one year old Haemophilus influenzae, invasive infection Hansen's disease (leprosy) Hantavirus infection Hemolytic uremic syndrome (HUS) Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Hepatitis syndrome, acute Influenza Legionellosis Listeriosis Lymphocytic choriomeningitis Lymphocytic choriomeningitis virus infection Lyme disease Malaria Measles Melioidosis Meningitis, bacterial, community-acquired Meningitis, viral (aseptic) or other infectious (non-bacterial) Meningococcal disease, invasive infection (with N. meningitidis) Mumps Norovirus infection Pertussis Plague Poliomyelitis Powassan Pox virus infections in humans, including variola (smallpox), monkeypox, vaccinia, and other orthopox or parapox viruses Psittacosis Q Fever Rabies in humans Respiratory infection due to a novel or unusual coronavirus, causing severe disease in humans including, but not limited to, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Reye syndrome Rickettsialpox Rocky Mountain spotted fever Rubella

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.100 continued

300.100: continued Salmonellosis Shigellosis Shiga toxin-producing organisms isolated from humans, including enterohemorrhagic E. coli (EHEC) Streptococcus pneumoniae, invasive infection in individuals younger than 18 years of age Tetanus Toxic shock syndrome Trichinosis Tularemia Typhoid Fever Typhus Varicella (chickenpox) Vibriosis (non-Cholera) Viral hemorrhagic fevers including, but not limited to, infection caused by Ebola virus, Marburg virus and other filoviruses, arenaviruses, bunyaviruses and flaviviruses Yersiniosis

300.110 Case Reports by Local Board of Health

300.110: Case Reports by Local Board of Health Each local board of health shall report to the Department the occurrence or suspected occurrence of any disease reported to the board of health, pursuant to 105 CMR 300.100. The case's full clinical data, demographic data and epidemiologic data, as defined by the Department, must be included for each report. Each local board of health shall utilize the secure electronic disease surveillance and case management system (MAVEN) designated and maintained by the Department. Each case shall be reported immediately, but no later than 24 hours after receipt by the local board of health.

300.120 Confidentiality

300.120: Confidentiality (A) All confidential personally identifying information, whether kept in electronic system or paper format including, but not limited to, reports of disease, clinical data, demographic data, and epidemiological data, notes, and memoranda, about any individual that is reported to or collected by the Department or local boards of health, or any individual or entity designated by the Department in accordance with 105 CMR 300.050, pursuant to 105 CMR 300.000 shall, unless disclosed as otherwise allowed in 105 CMR 300.120(A), be treated as confidential. Only those employees of the Department, local boards of health, or any individual or entity designated by the Department in accordance with 105 CMR 300.050, who have a specific need to review personal data records for the purposes allowed herein or otherwise required by law shall be entitled access to information contained in MAVEN and other such records. Any individual or entity making or receiving a report of disease shall ensure all paper records and electronic data systems related to information reported to or collected pursuant to 105 CMR 300.000 are treated as confidential in the same manner as information contained within MAVEN, kept secure and to the greatest extent possible kept in controlled access areas. Except when necessary for the Commonwealth's or local jurisdiction's disease investigation, control, treatment and prevention purposes, or for studies or research authorized by the commissioner pursuant to M.G.L. c. 111, § 24A, the Department and local boards of health or any individual or entity designated by the Department in accordance with 105 CMR 300.050, shall not disclose any personally identifying information without the individual's written consent. (B) Notwithstanding 105 CMR 300.120(A), the Department shall not disclose to the federal government, the Commonwealth or any of its political subdivisions or any agency, agent, or contractor of said Commonwealth or federal government, the identity of any individual with HIV or AIDS reported to the Department under 105 CMR 300.000.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.131 Illness Believed to Be Due to Food Consumption

300.131: Illness Believed to Be Due to Food Consumption Every person who is a health care provider or who is in a supervisory position at a school, day care, hospital, institution, clinic, medical practice, laboratory, labor or other camp who has knowledge of the occurrence or suspected occurrence of case or cases of illness believed to have been due to the consumption of food, shall report the same immediately by telephone, by facsimile or other electronic means to the local board of health in the community in which the facility is located or the Department directly. If the Department is notified directly, it shall notify the local board of health within 24 hours.

300.132 Illness Believed to Be Transmissible Through Food

300.132: Illness Believed to Be Transmissible Through Food The manager or supervisor of any food handling facility, when he or she knows or has reason to believe that an employee has contracted any disease transmissible through food or has become a carrier of such disease, shall report the same immediately by telephone, by facsimile or other electronic means to the local board of health in the community in which the facility is located or the Department directly. If the Department is notified directly, it shall notify the local board of health within 24 hours.

300.133 Illness Believed to Be Unusual

300.133: Illness Believed to Be Unusual In addition to the diseases listed in 105 CMR 300.100, every person who is a health care provider or who is in a supervisory position at a school, day care, hospital, institution, clinic, medical practice, laboratory, labor or other camp, employers, or, if necessary, other entities determined by the Department, who has knowledge of the occurrence of a case or a suspect case of an unusual illness, shall report the same immediately by telephone, by facsimile or other electronic means to the local board of health in the community in which the facility is located or contact the Department directly. If the Department is notified directly, it shall notify the local board of health within 24 hours.

300.134 Illness Believed to Be Part of a Suspected or Confirmed Cluster or Outbreak

300.134: Illness Believed to Be Part of a Suspected or Confirmed Cluster or Outbreak In addition to the diseases listed in 105 CMR 300.100, every person who is a health care provider or who is in a supervisory position at a school, day care, hospital, institution, clinic, medical practice, laboratory, labor or other camp, employers, or, if necessary, other entities determined by the Department, who has knowledge of the occurrence of any suspected or confirmed cluster or outbreak of any illness, shall report the same immediately by telephone, by facsimile or other electronic means to the local board of health in the community in which the facility is located or contact the Department directly. If the Department is notified directly, it shall notify the local board of health within 24 hours.

300.135 Reporting of Pediatric Influenza Deaths, Severe and Unusual Illness Due to Influenza, Cases of

300.135: Reporting of Pediatric Influenza Deaths, Severe and Unusual Illness Due to Influenza, Cases of Antiviral Treatment or Prophylaxis Failure, and Illnesses Believed to Be Due to Novel Influenza Viruses (A) Health care providers shall report to the Department within 24 hours, in a form or manner deemed acceptable by the Department: (1) All suspected and confirmed deaths due to influenza in pediatric patients and in pregnant women. Pediatric patients are defined as individuals younger than 18 years old; (2) All suspect or confirmed human cases of influenza that are unusual or unusually severe including, but not limited to, cases with encephalopathy, myocarditis or pericarditis; (3) All cases of influenza suspected or proven to be a result of resistance to an influenza antiviral agent; and (4) Suspect or confirmed cases of human infection due to influenza A viruses that are different from currently circulating human influenza H1 and H3 viruses. These viruses include those that are subtyped as nonhuman in origin and those that are unsubtypable with standard methods and reagents. (B) The Department will notify the local board of health via MAVEN of all such reports.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.136 Reporting of Infection or Suspected Infection Believed to Be Transmitted by a Transfused Blood

300.136: Reporting of Infection or Suspected Infection Believed to Be Transmitted by a Transfused Blood Product or Transplanted Organ, Tissue or Tissue Product In addition to the diseases listed in 105 CMR 300.100, every person who is a health care provider or who is in a supervisory position at a hospital, institution, clinic, medical practice, or laboratory, who has knowledge of the occurrence of a case or a suspect case of an infection or suspected infection that may be transmitted by a transfused blood product or transplanted organ, tissue, or tissue product, shall report the same immediately by telephone, by facsimile or other electronic means to the local board of health in the community in which the facility is located or contact the Department directly.

300.140 Reporting of Animal Diseases with Zoonotic Potential by Veterinarians

300.140: Reporting of Animal Diseases with Zoonotic Potential by Veterinarians As required under M.G.L. c. 129, § 28 any veterinarian or local board of health with knowledge of the existence of a domestic animal affected with, or suspected to be affected with a contagious disease must report the disease to the Department of Agricultural Resources (DAR), Bureau of Animal Health. DAR will immediately notify the Department of any suspicion or occurrence of any such disease if it is potentially infectious to humans. Notwithstanding requirements to report such cases to DAR, veterinarians shall also report to the Department within 24 hours any case of anthrax, plague, West Nile virus infection, or Eastern equine encephalitis virus infection diagnosed in an animal. The Department will notify the local board of health of all such reports within 24 hours.

300.150 Declaring a Disease or Condition Immediately Reportable, under Surveillance and/or Subject to

300.150: Declaring a Disease or Condition Immediately Reportable, under Surveillance and/or Subject to Isolation and Quarantine: Temporary Reporting, Surveillance and/or Isolation and Quarantine In addition to the diseases and conditions listed in 105 CMR 300.000, the Commissioner, as necessary to reduce morbidity and mortality in the Commonwealth, shall require the reporting, authorize the surveillance and/or establish isolation and quarantine requirements, on a time-limited basis, of confirmed and suspect cases of diseases or conditions which are newly recognized or recently identified or suspected to be a public health concern. Such declarations shall be initially authorized for a period of time not to exceed 12 months, at which point the declaration shall be reviewed to determine whether an extension of time, not to exceed 12 months, is necessary. If such additional time is necessary, the Department shall, during that time, determine whether the requirements should be continued pursuant to a revised regulation under 105 CMR 300.000. Specific requirements of a declaration issued under 105 CMR 300.150 may be updated to reflect changing conditions and understanding of the disease or condition as new data becomes available.

300.160 Diseases Reportable by Local Boards of Health to the Department

300.160: Diseases Reportable by Local Boards of Health to the Department Whenever there shall occur in any municipality, report of a case or condition listed in 105 CMR 300.000, a case of unusual illness or cluster or outbreak of disease, including but not limited to suspected food poisoning, or an increased incidence of diarrheal and/or unexplained febrile illness, it shall be the duty of the local board of health to report immediately by secure electronic disease surveillance and case management system (MAVEN) designated and maintained by the Department and, if indicated by the Department, by telephone the existence of such an unusual disease, outbreak, cluster, or increased incidence of illness to the Department. Information contained in the report shall be defined by the Department and shall include full demographic, clinical, epidemiologic and laboratory information. The case's full demographic data, clinical data, and epidemiologic data shall be included in each report.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.170 Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by

300.170: Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Laboratories In addition to the requirements of 105 CMR 300.100, 300.171, 300.180(A) and (C), all laboratories, including those outside of Massachusetts performing examinations on any specimens derived from Massachusetts residents that yield evidence of infection due to the organisms listed below, shall report such evidence of infection, including results identified through sequencing methods as specified by the Department, directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department, within 24 hours. A laboratory contact must be included with each report in addition to the test results, source of specimen, date of specimen collection, case's full name, date of birth, sex, race and ethnicity, address, telephone number, and name of the ordering health care provider. Where specified, additional demographic data, clinical data, or epidemiological data may be required. Upon receipt of a laboratory report, the Department shall notify the local board of health in the town in which the case resides within 24 hours via the MAVEN surveillance and case management system. Anaplasma sp. Arborviruses including, but not limited to, chikungunya virus, eastern equine encephalitis virus, dengue fever virus, Jamestown Canyon virus, West Nile virus, yellow fever virus, and Zika virus Babesia sp. Bacillus anthracis Bordetella bronchiseptica Bordetella holmseii Bordetella parapertussis Bordetella pertussis Borrelia burgdorferi Borrelia miyamotoi Brucella sp. Burkholderia mallei Burkholderia pseudomallei Campylobacter sp. Chlamydophila psittaci Clostridium botulinum Clostridium difficile Clostridium perfringens Clostridium tetani Corynebacterium diphtheriae Coxiella burnetii Cryptosporidium sp. Cyclospora cayetanensis Ehrlichia sp. Entamoeba histolytica Enteroviruses Escherichia coli O157:H7 Francisella tularensis Giardia sp. Group A streptococcus, from a usually sterile site Group B streptococcus, from a usually sterile site in children younger than one year old Haemophilus influenzae, from a usually sterile site Hantavirus Hemorrhagic fever viruses including, but not limited to, Ebola virus, Marburg virus, and other filoviruses, arenaviruses, bunyaviruses and flaviviruses Hepatitis A virus Hepatitis B virus Hepatitis C virus Hepatitis D virus Hepatitis E virus Evidence of human prion disease Influenza A and B viruses Legionella sp.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.170 continued

300.170: continued Listeria sp. Lymphocytic choriomeningitis virus Measles virus Mumps virus Mycobacterium leprae Mycobacterium tuberculosis, M. africanum, M. bovis Neisseria meningitidis, from a usually sterile site Noroviruses Novel or unusual coronaviruses causing severe disease Novel influenza A viruses Plasmodium sp. including P. falciparum, P. malariae, P. ovale. P. vivax Poliovirus Powassan virus Pox viruses including, but not limited to, variola, vaccinia, and other orthopox and parapox viruses, but excluding molluscum contagiosum viruses Rabies virus Rickettsia akari Rickettsia prowazekii Rickettsia rickettsii Rubella virus Salmonella sp. SARS-CoV-2 Shiga toxin-producing organisms Shigella sp. Simian herpes virus Streptococcus pneumoniae, from a usually sterile site in individuals younger than 18 years old Trichinella spiralis Laboratory evidence of tuberculosis infection Varicella zoster virus Vibrio sp. Yersinia pestis Yersinia sp. Evidence of infection due to the organisms listed below shall also be reported directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department, within 24 hours. A laboratory contact must be included with each report in addition to the test results, source of specimen, date of specimen collection, case's full name, date of birth, sex, race and ethnicity, address, telephone number, and name of the ordering health care provider. Where specified, additional demographic data, clinical data, or epidemiological data may be required. Chlamydia trachomatis Haemophilus ducreyi Herpes simplex virus, neonatal infection (in child younger than 60 days old) Human immunodeficiency virus (HIV) Klebsiella granulomatis Neisseria gonorrhoeae Treponema pallidum

300.171 Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test

300.171: Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test Results (Antibiograms) (A) All Laboratories shall report results indicating antimicrobial resistance in the following organisms directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department. Information shall include the name of a laboratory contact, the specified test results, date of specimen collection, source of specimen, and the case's full name, date of birth, sex, race and ethnicity, full address, telephone number, and name of the ordering health care provider, when available.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.171 continued

300.171: continued Carbapenemase-producing and/or carbapenem-resistant Enterobacteriacea Neisseria gonorrhoeae resistant to ceftriaxone Vancomycin-resistant Staphylococcus aureus (VRSA) Vancomycin-intermediate Staphylococcus aureus (VISA) Invasive methicillin-resistant Staphyloccus aureus (MRSA) Invasive penicillin-resistant Streptococcus pneumoniae If antimicrobial resistance of an unexplained or novel nature is identified in any infectious organism, the laboratory must contact the Department within five business days. (B) All hospitals shall report annual cumulative antibiotic susceptibility test results (antibio- grams). This report shall include information specified by the Department and be sent in the manner deemed acceptable by the Department.

300.172 Submission of Selected Isolates and Diagnostic Specimens to the State Public Health Laboratory

300.172: Submission of Selected Isolates and Diagnostic Specimens to the State Public Health Laboratory All laboratories shall submit the following directly to the State Public Health Laboratory for further examination. Bacillus anthracis isolates and suspect isolates Brucella sp. isolates and suspect isolates Burkholderia mallei isolates and suspect isolates Burkholderia pseudomallei isolates and suspect isolates Carbapenem-resistant and carbapenemase producing Enterobacteriacea isolates Campylobacter sp. isolates Clostridium botulinum isolates and suspect isolates Specimens obtained from human sources with indication or suspicion of eastern equine encephalitis (EEE) virus infection Francisella tularensis isolates and suspect isolates Haemophilus influenzae isolates from a usually sterile site Influenza viruses diagnostic specimens or isolates known or suspected to contain antiviral resistant virus Legionella sp., isolates and suspect isolates Listeria monocytogenes isolates Specimens with indication or suspicion of measles virus infection Specimens with indication or suspicion of mumps virus infection Mycobacterium tuberculosis Neisseria gonorrhoeae isolates Neisseria meningitidis isolates from a usually sterile site Salmonella sp. isolates SARS-CoV-2 isolates Shiga toxin producing organism isolates including E. coli O157, and any broths which test positive for shiga toxin producing organisms where the organism has not been isolated Shigella sp. isolates Staphylococcus aureus, vancomycin-intermediate and vancomycin-resistant isolates only Streptococcus pneumoniae isolates from a usually sterile site and only from individuals younger than 18 years old Vibrio sp. isolates Specimens obtained from human sources with indication or suspicion of West Nile virus infection Yersinia pestis isolates and suspect isolates Yersinia sp. (non pestis) isolates Organisms with antimicrobial resistance of a novel nature Where necessary for the investigation, monitoring, control and prevention of diseases dangerous to the public health, the Department may require added specimens or isolates from organisms listed in 105 CMR 300.170 be submitted to the State Public Health Laboratory for further examination.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.173 Reporting of Certain Negative and Indeterminant Diagnostic Tests Associated with Ascertainment

300.173: Reporting of Certain Negative and Indeterminant Diagnostic Tests Associated with Ascertainment of Infection Status All laboratories performing examinations on any specimens derived from Massachusetts residents shall report directly to the Department through secure electronic laboratory mechanisms, or other method, as defined by the Department, within 24 hours, negative results of the following specific laboratory tests: (1) Any test for syphilis associated with a concurrent positive serologic test; (2) Hepatitis C serologic and nucleic acid amplification tests; (3) Any negative or indeterminate diagnostic test result for HIV infection associated with a concurrent positive test; (4) Any tests that are part of a panel of diagnostic tests for vector-borne infections that are associated with a concurrent positive result of one or more tests in the panel; (5) Any tests that are part of a panel of diagnostic tests for viral hepatitis infections that are associated with a concurrent positive result of one or more tests in the panel; (6) Any negative diagnostic test result for SARS-CoV-2; and (7) Any other negative or indeterminate test as determined by the Department, when necessary for the investigation, monitoring, control and prevention of diseases dangerous to the public health.

300.174 Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by

300.174: Laboratory Findings Indicative of Infectious Disease Reportable Directly to the Department by Point of Care Testing Physicians and other healthcare providers using point of care tests for diagnosis of infectious diseases must report test results to the Department when they are indicative of an infectious disease reportable directly to the Department by laboratories (per 105 CMR 300.170), unless such point of care testing is subject to routine reflex testing by a supplementary or confirmatory testing the results of which would be reportable.

300.175 Potential Exposures to Certain Infectious Agents in Clinical Laboratories and Research Settings

300.175: Potential Exposures to Certain Infectious Agents in Clinical Laboratories and Research Settings Reportable Directly to the Department Any person who is in a supervisory position at a human or veterinary diagnostic or research laboratory located in Massachusetts who has knowledge that a human has had exposure to certain infectious agents in the laboratory, shall report the same immediately by telephone to the Department. These infectious agents include, but are not necessarily limited to, Bacillus anthracis (excluding Sterne strains), Brucella suis, Brucella melitensis, Brucella abortus, Brucella canis, Brucella sp. vaccine strains, Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis, Neisseria meningitidis, and Yersinia pestis In addition, bites, scratches or contact with body fluids from macaque monkeys shall be reported in the same manner.

300.180 Diseases Reportable Directly to the Department

300.180: Diseases Reportable Directly to the Department (A) Reporting of Suspect or Confirmed Active Tuberculosis Disease. Any health care provider, laboratory, board of health or administrator of a city, state or private institution or hospital who has knowledge of a case of confirmed tuberculosis or clinically suspected tuberculosis, as defined in 105 CMR 300.020, shall notify the Department within 24 hours by telephone, in writing, by facsimile or other electronic means, as defined by the Department. When available, full demographic, epidemiologic, clinical and laboratory information on the case, as defined by the Department shall be included in each report. Upon receipt of such notice, the Department shall notify the local board of health in the community where the case resides via MAVEN. (B) Reporting of Tuberculosis Infection (also known as Latent Tuberculosis Infection). Any health care provider, board of health or administrator of a city, state or private institution or hospital who has knowledge of a case of tuberculosis infection as determined by skin test or other test for determining the presence of tuberculosis infection shall notify the Department in a written or electronic format as designated by the Department. A skin test for tuberculosis which meets criteria for indicating tuberculosis infection according to the published guidelines of the U.S. Centers for Disease Control and Prevention or the Department is itself reportable. When available, full demographic, epidemiologic, clinical and laboratory information on the case, as defined by the Department shall be included in each report.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.180 continued

300.180: continued (C) Any health care provider, laboratory, board of health or administrator of a city, state or private institution or hospital who has knowledge of the diseases listed as follows shall notify the Department within 24 hours, by telephone, in writing, by facsimile or other electronic means, as defined by the Department. When available, full demographic, epidemiologic, and clinical and laboratory information on the case, as defined by the Department must be included in each report. Acquired immunodeficiency syndrome (AIDS); Chancroid; Chlamydial infection; Gonorrhea; Granuloma inguinale; Herpes simplex infection, neonatal (onset within 60 days after birth); Human immunodeficiency virus (HIV) infection; Lymphogranuloma venereum; Ophthalmia neonatorum caused by any agent; Pelvic inflammatory disease of any etiology; and Syphilis. (D) The following work-related diseases and injuries are reportable directly to the Department by physicians and other health care providers in a manner approved by the Department no later than ten days after diagnosis or identification. Said report must include, at a minimum, the reporter’s name and address; the patient’s name, address, telephone number, age and sex, race/ethnicity, if known; the employer’s name and location where the occupational exposure or injury reportedly occurred; the diagnosis of the disease or description of the injury; the patient’s occupation if known; and any other information as requested by the Department. (1) Occupational Lung Disease. (a) Asbestosis; (b) Silicosis; (c) Beryllium disease; (d) Chemical pneumonitis; (e) Asthma caused by or aggravated by workplace exposures; and (f) Other work-related lung disease. (2) Work-related Heavy Metal Absorption. (a) Mercury (blood >15 mcg/L: urine > 35 mcg/grams creatinine); (b) Cadmium (blood > 5mcg/L: urine > 5 mcg/grams creatinine); and (c) Other. (3) Work-related Acute Chemical Poisoning. (a) Carbon monoxide poisoning; (b) Pesticide poisoning; (c) Other; and (d) Work-related Carpal Tunnel Syndrome. (E) Reporting of Work-related Traumatic Injuries to a Person Younger than 18 Years Old. (1) By Health Care Facilities. Work-related traumatic injuries to persons younger than 18 years old that are treated in a hospital or other health care facility shall be reported by the person in charge of the facility or their designee. Health care facilities shall report these cases through computer generated reports on a regular basis no less than once every six months. Said reports shall include similar information to that required under 105 CMR 300.180(D). (2) By Physicians and Other Health Care Providers. Serious work-related traumatic injuries to persons younger than 18 years old shall be reported to the Department by the physician or other health care provider who treats the minor, within ten days after the physician or health care provider initially treats the injury. Physicians and other health care providers may report all work-related traumatic injuries to persons younger than 18 years old. Said reports shall include similar information to that required under 105 CMR 300.180(D).

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.181 Reporting Work-related Disease Outbreaks

300.181: Reporting Work-related Disease Outbreaks Any physician or other health care provider who shall have knowledge of a work-related disease outbreak, regardless of whether or not the disease is included on the reportable disease list, shall report it immediately by telephone, in writing, by facsimile, or other electronic means to the Department.

300.182 Joint Authority with Department of Labor and Workforce Development

300.182: Joint Authority with Department of Labor and Workforce Development The Department recognizes that the Department of Labor and Workforce Development also has the authority, pursuant to M.G.L. c.149, § 11, to require reporting of work-related diseases and conditions. In order to avoid duplicate reporting, the Department will, upon designation by the Department of Labor and Workforce Development, also serve as the agent of the Department of Labor and Workforce Development for collection of reports of work-related diseases and conditions required under M.G.L. c. 149, § 11.

300.190 Surveillance and Control of Diseases Dangerous to the Public Health

300.190: Surveillance and Control of Diseases Dangerous to the Public Health The Department and local boards of health are authorized to conduct surveillance activities necessary for the investigation, monitoring, control and prevention of diseases dangerous to the public health. Such activities shall include, but need not be limited to: (A) Systematic collection and evaluation of morbidity and mortality reports. This includes the collection and analysis of data derived from electronic health record systems.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.190 continued

300.190: continued (B) Investigation into the existence of diseases dangerous to the public health to determine the causes and extent of such diseases and to formulate prevention and control measures. (C) Identification of cases and contacts. (D) Counseling and interviewing individuals as appropriate to assist in positive identification of exposed individuals and to develop information relating to the source and spread of illness. (E) Monitoring the medical condition of individuals diagnosed with or exposed to diseases dangerous to the public health. (F) Collection and/or preparation of data concerning the availability and use of vaccines, immune globulins, insecticides and other substances used in disease prevention and control. (G) Collection and/or preparation of data regarding immunity levels in segments of the population and other relevant epidemiological data. (H) Ensuring that diseases dangerous to the public health are subject to the requirements of 105 CMR 300.200 and other proper control measures.

300.191 Access to Medical Records and Other Information

300.191: Access to Medical Records and Other Information (A) The Department or local boards of health are authorized to obtain, upon request, from health care providers and other persons subject to the provisions of 105 CMR 300.000, access to medical records, including electronic health records, and other information that the Department or the local board of health deems necessary to carry out its responsibilities to investigate, monitor, prevent and control diseases dangerous to the public health. (B) School nurses are authorized to obtain from health care providers the immunization records or other immunization related information required for school admission, without the authorization of the child's parent(s) or legal guardian(s), as necessary to carry out the immuniza- tion requirements of M.G.L. c. 76, § 15. Prior to requesting such records from the provider, school nurses shall make a good faith effort to obtain the information from the child's parent(s) or legal guardian(s) and shall notify them that the information will be obtained from the health care provider pursuant to 105 CMR 300.191 if it is not provided in a timely manner by the parent(s) or guardian(s). For purposes of the Health Insurance Portability and Accountability Act (HIPAA), school nurses are hereby designated as public health authorities and granted authority to obtain immunization information from health care providers in accordance with 105 CMR 300.000 in order to monitor and ensure compliance with the immunization requirements of M.G.L. c. 76, § 15. (C) When, in the determination of the commissioner, it is necessary for the investigation, monitoring, control and prevention of diseases dangerous to the public health, the Department may require health care providers and other persons subject to the provisions of 105 CMR 300.000 report specified information from medical records, including electronic health records, to the Department.

300.192 Surveillance of Diseases Possibly Linked to Environmental Exposures

300.192: Surveillance of Diseases Possibly Linked to Environmental Exposures The Department is authorized to collect medical records and other identifiable information from health care providers and other persons subject to 105 CMR 300.000, and/or prepare data, as detailed in 105 CMR 300.190 and 300.191, on individuals evaluated for or diagnosed with the following diseases possibly linked to environmental exposures: Amyotrophic lateral sclerosis (ALS); Aplastic anemia; Asthma; Autism spectrum disorder (ASD); Multiple sclerosis (MS);

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.192 continued

300.192: continued Myelodysplastic syndrome (MDS); Scleroderma; Systemic lupus erythematosus.

300.193 Surveillance of Injuries Dangerous to Public Health

300.193: Surveillance of Injuries Dangerous to Public Health The Department is authorized to collect medical records and other identifiable information from health care providers and other persons subject to 105 CMR 300.000, and/or prepare data, as detailed in 105 CMR 300.190 and 300.191, related to the following types of injuries or causes of injuries: Any mode of transportation; Assaults or homicides; Drownings; Falls; Fires; Machinery; Poisoning, including, but not limited to, drug overdose; Spinal cord injuries; Strikes by/against another object or person; Suffocation; Suicides, attempted suicides, or self-inflicted wounds; Traumatic amputations; Traumatic brain injuries; Weapons; Work-related injuries.

300.200 Isolation and Quarantine Requirements

300.200: Isolation and Quarantine Requirements Upon the report of a case or suspected case of disease declared dangerous to the public health, the local board of health and the Department are authorized to implement and enforce the requirements outlined in 105 CMR 300.200. Minimum requirements for the isolation and quarantine of diseases dangerous to the public health are set forth in 105 CMR 300.200(A). Depending on the specific circumstances related to the exposure, case and/or contact with respect to any disease or condition listed in 105 CMR 300.200(A) or (B), additional control measures may be required. (A) Diseases Reportable to Local Boards of Health. DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts AmebiasisAfter diarrhea has resolved, food handlers may only return to food handling duties after producing one negative stool specimen. If a case has been treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. In outbreak circumstances, two negative stool specimens produced at least 24 hours apart will be required prior to returning to food handling duties. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. AnaplasmosisNo restrictionsNo restrictions AnthraxFor cutaneous anthrax, place on contact precautions until lesions are healed or free from anthrax bacilli. No restrictions Arbovirus infectionNo restrictionsNo restrictions BabesiosisNo restrictions except for exclusion from blood donation. No restrictions B. miyamotoiNo restrictionsNo restrictions

300.200 continued

300.200: continued

105 CMR: DEPARTMENT OF PUBLIC HEALTH DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts BotulismNo restrictionsNo restrictions BrucellosisNo restrictionsNo restrictions Campylobacteriosis After diarrhea has resolved, food handlers may only return to food handling duties after producing one negative stool specimen. If a case has been treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. In outbreak circumstances, two negative stool specimens produced at least 24 hours apart will be required prior to returning to food handling duties. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. CholeraAfter diarrhea has resolved, food handlers may only return to food handling duties after producing two negative stool specimens produced at least 24 hours apart. If a case has been treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. Clostridium difficileNo restrictionsNo restrictions Infection due to coronavirusesSubject to recommendations based on the specific coronavirus infection as determined by the Department based on the most current recommendations by the Centers for Disease Control and Prevention. Subject to recommendations based on the specific coronavirus exposure as determined by the Department. Creutzfeldt-Jakob disease or variant Creutzfeldt-Jakob disease No restrictionsNo restrictions CryptosporidiosisAfter diarrhea has resolved, food handlers may only return to food handling duties after producing one negative stool specimen. If a case has been treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. In outbreak circumstances, two negative stool specimens produced at least 24 hours apart will be required prior to returning to food handling duties. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. CyclosporiasisFood handlers may return to food handling duties after diarrhea has resolved. In certain situations however, food handlers may be required to produce one or two negative stool specimens before returning to food handling duties. If a case has been treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In certain outbreak situations, asymptomatic contacts who are food handlers may be required to produce one or two negative stool specimens prior to returning to food handling duties. Otherwise, no restrictions.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued

DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts

DiphtheriaMaintain isolation until two successive

pairs of nose and throat cultures (and

cultures of skin lesions in cutaneous

diphtheria) obtained greater than 24

hours apart and at least 24 hours after

completion of antimicrobial therapy are

negative. If there was no antimicrobial

therapy, these two sequential pairs of

cultures shall be taken after symptoms

resolve and greater than two weeks after

their onset. If an avirulent (nontoxigenic)

strain is documented, isolation is not

necessary.

All contacts (both symptomatic and

asymptomatic) who are food handlers must be

excluded from work until two successive pairs

of nose and throat cultures obtained greater

than two weeks after completion of

antimicrobial prophylaxis (if any) and greater

than 24 hours apart are negative. Symptomatic

contacts who are not food handlers shall be

considered the same as a case until their culture

results are negative and they are cleared by the

appropriate public health authority.

Asymptomatic contacts who are not

foodhandlers must be on appropriate antibiotics

and personal surveillance.

EhrlichiosisNo restrictionsNo restrictions

Encephalitis, any case No restrictionsNo restrictions

Food poisoning and toxicityNo restrictionsNo restrictions

GiardiasisAfter diarrhea has resolved, food handlers

may only return to food handling duties

after producing one negative stool

specimen. If a case has been treated with

an antimicrobial, the stool specimen shall

not be collected until at least 48 hours

after cessation of therapy. In outbreak

circumstances, two negative stool

specimens produced at least 24 hours

apart will be required prior to returning to

food handling duties.

Contacts with diarrhea, who are food handlers,

shall be considered the same as a case and

handled in the same fashion. In outbreak

circumstances, asymptomatic contacts who are

food handlers shall be required to produce two

negative stool specimens produced at least 24

hours apart prior to returning to food handling

duties. Otherwise, no restrictions.

GlandersNo restrictionsNo restrictions

Group A streptococcus,

invasive infection

Persons with streptococcal pharyngitis or

skin infections, with or without invasive

disease, shall not return to school or child

care until at least 24 hours after initiating

antimicrobial treatment.

Personal surveillance and prophylaxis with an

antimicrobial when appropriate. Otherwise, no

restrictions.

Group B streptococcus,

invasive infection

No restrictionsNo restrictions

Haemophilus influenzae,

invasive infection

1. type B
2. non type B

Until 24 hours after initiating

antimicrobial treatment.

No restrictions

Personal surveillance and prophylaxis with an

appropriate antimicrobial when indicated by

clinical situation of the contact or by potential

for transmission. Otherwise, no restrictions.

No restrictions

Hansen’s diseaseNo restrictions if under medical care.No restrictions

Hantavirus infection No restrictionsNo restrictions

Hemolytic uremic syndromeAfter diarrhea has resolved, food handlers

may only return to food handling duties

after producing two negative stool

specimens, produced at least 24 hours

apart. If a case was treated with an

antimicrobial, the stool specimen shall not

be collected until at least 48 hours after

cessation of therapy.

Contacts with diarrhea, who are food handlers,

shall be considered the same as a case and

handled in the same fashion. In outbreak

circumstances, asymptomatic contacts who are

food handlers shall be required to produce two

negative stool specimens produced at least 24

hours apart prior to returning to food handling

duties. Otherwise, no restrictions.

300.200 continued

300.200: continued DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts

105 CMR: DEPARTMENT OF PUBLIC HEALTH Hepatitis AIsolation until one week after onset of symptoms or for cases where the onset date is not known, one week past the date the specimen positive for IgM antibody to HAV was provided. No restrictions except for susceptible food handlers, who shall be excluded from their occupations for 28 days unless they receive a prophylactic dose of immune globulin (IG) and/or hepatitis A vaccine within 14 days of exposure, or in accordance with the latest recommendations from the Department. Hepatitis BNo restrictions except for exclusion from organ and blood donation. Case shall receive counseling to modify activities in order to prevent transmission. Personal surveillance for high-risk contacts who should receive hepatitis B immune globulin (HBIG) and vaccine. Infants born to infected women should also receive HBIG and vaccine. Otherwise, no restrictions. Hepatitis CNo restrictions except for exclusion from organ and blood donation. Case shall receive counseling to modify activities in order to prevent transmission. Personal surveillance for high-risk contacts. Otherwise, no restrictions. Hepatitis DSame as co-infecting hepatitis BSame as co-infecting hepatitis B Hepatitis EIsolation until one week after onset of symptoms, or for cases where the onset date is not known, one week past the date of the specimen positive for evidence of acute hepatitis E was provided. No restrictions, except for susceptible food handlers, who shall be excluded from their occupations for 28 days. InfluenzaNo restrictionsNo restrictions LegionellosisNo restrictionsNo restrictions ListeriosisNo restrictionsNo restrictions Lyme diseaseNo restrictionsNo restrictions Lymphocytic choriomeningitis virus infection No restrictions, except for exclusion from organ and blood donation No restrictions MalariaNo restrictions except for exclusion from blood donation. No restrictions MeaslesThrough four days after onset of rash (counting the day of rash onset as day zero). Contacts born in or after 1957, who are not appropriately immunized or do not have laboratory evidence of immunity, will be excluded from work, classes or other public activities from the fifth through the 21 day st after their exposure even if they receive immune globulin. If exposure was continuous and/or if multiple cases occur, susceptibles will be excluded through the 21 day after rash st onset in the last case. Health care workers and inpatients, regardless of year of birth, who are not appropriately immunized or do not have laboratory evidence of immunity, will be excluded from work (health care workers) or isolated with airborne precautions (inpatients) from the fifth day after their first exposure through the 21 day after their last exposure. st These restrictions for health care workers and inpatients remain even if the contact received IG or was vaccinated post-exposure. MelioidosisNo restrictionsNo restrictions

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts Meningitis a) bacterial, community- acquired b) viral (aseptic), and other non-bacterial If infected with H. influenzae or N. meningitidis, droplet precautions until 24 hours after initiation of appropriate antibiotic therapy. Otherwise, no restrictions. No restrictions Personal surveillance and antibiotic prophylaxis, where appropriate, if case has H. influenzae or N. meningitidis. Otherwise, no restrictions. No restrictions Meningococcal disease, invasive infection Droplet precautions until 24 hours after initiation of appropriate antibiotic therapy. Otherwise, no restrictions. Personal surveillance and antibiotic prophylaxis, where appropriate. Otherwise no restrictions. MonkeypoxUntil lesions have dried and crusts have separated. If no lesions, until seven days after onset of fever. Personal surveillance. Otherwise no restrictions. MumpsThrough five days after onset of gland swelling (counting the initial day of gland swelling as day zero). Contacts born in or after 1957, who are not appropriately immunized or do not have laboratory evidence of immunity, will be excluded from work, classes or other public activities from the 12 through the 25 day thth after their exposure. When multiple cases occur, susceptibles need to be excluded through 25 days after the onset of the last case. Health care workers, and inpatients, regardless of year of birth, who are not appropriately immunized or do not have laboratory evidence of immunity will be excluded from work (health care workers) or isolated with droplet precautions (inpatients) from the 12 through the 25 date thth after their exposure. NorovirusesFood handlers must be excluded from food handing duties for either 72 hours past the resolution of symptoms or 72 hours past the date the specimen positive for norovirus was produced, which ever occurs last. Contacts with diarrhea or vomiting who are food handlers shall be excluded from food handling duties for 72 hours past the resolution of symptoms. PertussisUntil 21 days from onset of cough or five days after initiation of appropriate antibiotic therapy. If the contact is symptomatic, use same restrictions as for cases. If the contact is an asymptomatic healthcare worker not receiving antibiotic prophylaxis, exclude from the workplace for 21 days after last exposure or, if unknown, for 21 days after the onset of the last case in the setting. If the contact is asymptomatic, not a healthcare worker, and exposed within the last 21 days, s/he should receive antibiotic prophylaxis but no exclusion is generally required. In certain situations deemed to be high-risk, the public health authority may require exclusion of asymptomatic contacts not receiving antibiotic prophylaxis and/or other contacts, and/or may extend the exclusion period beyond 21 days up to a maximum of 42 days.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued

DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts

PlagueFor pneumonic plague, droplet

precautions until 72 hours after initiation

of appropriate antibiotic therapy. For

bubonic plague, case shall be placed on

contact precautions until 48 hours after

initiation of effective therapy.

Contacts of cases of pneumonic plague should

be provided prophylaxis and placed under

personal surveillance for seven days; those who

refuse prophylaxis shall be placed in quarantine

and under personal surveillance for seven days.

PoliomyelitisPlace case on enteric precautions for six

weeks after onset of symptoms or until

poliovirus can no longer be recovered

from feces (the number of negative

specimens required will be determined by

the Department on a case-by-case basis).

According to applicable Department guidelines,

administer an appropriate preparation of polio

virus vaccine if the immune status is unknown

or incomplete. Otherwise, no restrictions.

PowassanNo restrictionsNo restrictions

PsittacosisNo restrictionsNo restrictions

Q FeverNo restrictionsNo restrictions

Rabies- human For duration of illnessPost-exposure prophylaxis of contacts when

appropriate, using recommendations of the

Department. Otherwise, no restrictions.

Reye SyndromeNo restrictionsNo restrictions

RickettsialpoxNo restrictionsNo restrictions

Rocky Mountain spotted feverNo restrictionsNo restrictions

Rubella

1. Congenital
2. Non-Congenital

Isolation from susceptible persons for the

first year of life or until two cultures of

clinical specimens (nasopharyngeal

secretions or urine) obtained one month

apart after age three months are negative

for rubella virus.

Until seven days after onset of rash

(counting the day of rash onset as day

zero).

No restrictions except for susceptibles, then

same as for non-congenital rubella.

Contacts born in or after 1957, who are not

appropriately immunized or do not have

laboratory evidence of immunity, will be

excluded from work, classes or other public

activities from the seventh through the 23 day

rd

after their last exposure. When multiple cases

occur, susceptibles need to be excluded until 23

days after the onset of the last case.Health care

workers inpatients, regardless of year of birth,

who are not appropriately immunized or do not

have laboratory evidence of immunity, will be

excluded from work (health care workers) or

isolated with droplet precautions (inpatients)

from the seventh day after first exposure

through the 23 day after their last exposure.

rd

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts Salmonellosis a) Not including typhoid fever b) S. typhi (typhoid fever) After diarrhea has resolved, food handlers may only return to food handling duties after producing one negative stool specimen. If a case was treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. In outbreak circumstances, two negative stool specimens produced at least 24 hours apart will be required prior to returning to food handling duties. Food handlers may only return to food handling duties after producing three consecutive negative stool specimens each produced no less than 48 hours apart and one month after onset of first symptoms. If one culture is positive, repeat cultures shall be collected at one month intervals until three consecutive negative cultures are obtained. If the case has been treated with an antimicrobial, the first stool specimen shall not be collected until 48 hours after cessation of therapy. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. All food handlers, symptomatic or asymptomatic, who are contacts of a typhoid case shall be considered the same as a case and handled in the same fashion. Shiga toxin-producing organisms, including E. coli O157:H7 After diarrhea has resolved, food handlers may only return to food handling duties after producing two negative stool specimens, produced at least 24 hours apart. If a case was treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. ShigellosisAfter diarrhea has resolved, food handlers may only return to food handling duties after producing two negative stool specimens produced at least 24 hours apart. If a case was treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions. Smallpox In conjunction with public health authorities, place case(s) on highest level of isolation to prevent direct contact, droplet contact and airborne exposure until lesions have dried and crusts have separated. Afebrile contacts shall be placed under fever surveillance (quarantine) for 18 days from the last contact or 14 days from successful vaccination (which ever comes first), with monitoring and recording of temperature twice daily (morning and evening). Febrile contacts with or without rash shall be considered the same as a case and handled in the same fashion (isolation). If no rash develops after five days and the fever is diagnosed as being caused by recent vaccination or some other non-smallpox etiology, contact may be released from isolation to home to continue fever surveillance for 18 days following their last contact with a case or 14 days following successful vaccination (whichever comes first).

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued DiseaseMinimum Period of Isolation of PatientMinimum Period of Quarantine of Contacts Streptococcus pneumoniae, invasive infection No restrictionsNo restrictions TetanusNo restrictionsNo restrictions Toxic shock syndromeNo restrictionsNo restrictions TrichinosisNo restrictionsNo restrictions TularemiaNo restrictionsNo restrictions TyphusNo restrictionsNo restrictions Varicella (chickenpox)If vesicles are present, until lesions have dried and crusted, or until no new lesions appear, usually by the fifth day (counting the day of rash onset as day zero). If no vesicles are present, until the lesions have faded (i.e. the skin lesions are in the process of resolving; lesions do not need to be completely resolved) or no new lesions appear within a 24-hour period, whichever is later. Contacts in non-health care settings, who are not appropriately immunized or are without laboratory evidence of immunity or a reliable history of chickenpox, shall be excluded from school, work or other public activities from the eighth through the 21 days after their exposure st to the case during the case's infectious period. If the exposure was continuous, contacts shall be excluded from the eighth through the 21 st days after the case's rash onset. Neonates born to mothers with active varicella shall be isolated from susceptibles until 21 days of age. Health care workers who are not appropriately immunized or are without laboratory evidence of immunity shall be excluded from work (health care workers) or isolated with airborne precautions (inpatients) from the eighth day after their first exposure through the 21 day st after the last exposure. In all settings, anyone receiving varicella zoster immune globulin (VZIG) or intravenous immune globulin (IVIG) shall extend their exclusion to 28 days post-exposure. Vibriosis (non- Cholera)Food handlers with diarrhea may return to work after diarrhea has resolved. No restrictions Viral hemorrhagic feversPlace on hemorrhagic fever specific barrier precautions with airborne, contact, and droplet precautions, and double gloving, with strict hand hygiene, impermeable gowns, face shields, eye protection, and leg and shoe coverings until clinical illness has resolved. Personal surveillance YersiniosisAfter diarrhea has resolved, food handlers may only return to food handling duties after producing one negative stool specimen. If a case was treated with an antimicrobial, the stool specimen shall not be collected until at least 48 hours after cessation of therapy. In outbreak circumstances, two negative stool specimens produced at least 24 hours apart will be required prior to returning to food handling duties. Contacts with diarrhea, who are food handlers, shall be considered the same as a case and handled in the same fashion. In outbreak circumstances, asymptomatic contacts who are food handlers shall be required to produce two negative stool specimens produced at least 24 hours apart prior to returning to food handling duties. Otherwise, no restrictions.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.200 continued

300.200: continued (B) Diseases Reportable Directly to the Department of Public Health. DiseaseMinimum Period of Isolation of Patient Minimum Period of Quarantine of Contacts Tuberculosis a) Active tuberculosis: Pulmonary (also includes mediastinal, laryngeal, pleural, or miliary) b) Active tuberculosis: Extra-pulmonary c) Latent TB infection Clearance from isolation in the community requires one or more of the following: three appropriately collected and processed sputum smears that are collected in eight – 24 hour intervals (one of which should be an early morning specimen); or other FDA cleared/approved or generally accepted laboratory tests indicating tuberculosis is unlikely or infectiousness is unlikely, as per guidelines such as those of the CDC, the Advisory Council of the Elimination of Tuberculosis (ACET) or the American Thoracic Society (ATS); or until the patient has undergone a period of effective chemotherapy in accordance with current treatment standards, such as those of CDC, ACET or ATS, and there is demonstration of clinical improvement (i.e. decreasing cough, reduced fever, resolving lung infiltrates). No restrictions except for appropriate handling of infected fluids. No restrictions No restrictions of asymptomatic contacts required. No restrictions No restrictions (C) Standard Precautions. In addition to the specific practices set out in 105 CMR 300.000, standard precautions should be followed when treating all patients and contacts. The Department adopts, by reference, as standard practice for infection control, the most current version of the guidelines on the prevention of transmission of infection published by the U.S. Centers for Disease Control and Prevention and its Healthcare Infection Control Practices Advisory Committee. (D) Work-related Diseases and Injuries Reportable Directly to the Department of Public Health. As these diseases are not communicable, each case should be evaluated individually regarding a return to work.

300.210 Procedures for Isolation and Quarantine

300.210: Procedures for Isolation and Quarantine (A) Scope. (1) The Department through an authorized agent shall, and local boards of health are encouraged to strongly comply with the provisions of 105 CMR 300.210(B) through (I) when implementing isolation or quarantine. (2) The procedures set forth in 105 CMR 300.210(B) through (I) are applicable to isolation and quarantine of persons in the population at large, but do not apply to persons in the custody of correctional facilities operated by the Department of Correction, persons in the custody of county houses of correction, persons in the custody of city or town jails, or to youth detained by or committed to the Department of Youth Services. (3) Notwithstanding 105 CMR 300.210(A)(1) and (2), the Department and local boards of health shall follow the procedures set forth in M.G.L. c. 111, §§ 94A through 94H when isolating individuals with active tuberculosis who are unwilling or unable to accept proper medical treatment and who thereby pose a serious danger to public health.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.210 continued

300.210: continued (B) General. (1) Voluntary Compliance. (a) Before using mandatory measures, the Department or local board of health shall educate the individual or group about the reasons and requirements for isolation or quarantine, and shall attempt to secure voluntary compliance. (b) When an individual or group agrees to comply voluntarily with isolation or quarantine, no written or oral order shall be necessary. (2) Least Restrictive Setting. Isolation or quarantine shall take place in the least restrictive setting that complies with the requirements of 105 CMR 300.200. (3) Types of Orders. Orders for isolation and quarantine may include, but are not limited to, restricting individuals or groups from being present in certain places including but not limited to school or workplace; restriction to residence and/or workplace; and confinement in other private or public premises. Such other premises shall not include a jail, prison, or other correctional facility. (4) Time Period of Order. An order that has not expired shall be rescinded when the individual or group no longer poses a serious danger to public health. (C) Written Order. (1) The Department or local board of health may issue a written order of isolation or quarantine to an individual or group of individuals as authorized by 105 CMR 300.000. (2) A copy of the written order shall be provided to the individual to be isolated or quarantined. If the order applies to a group of individuals and it is impractical to provide individual copies, the order may be posted in a conspicuous place in the isolation or quarantine premises. (D) Temporary Isolation or Quarantine through Oral Order. (1) The Department or local board of health may temporarily isolate or quarantine an individual or group of people as authorized by 105 CMR 300.000 through an oral order only if delay in imposing the isolation or quarantine would pose a serious, imminent danger to the public health. (2) The individual or group shall be orally informed that the order may be appealed by telephoning a specified health official issuing the order at a stated telephone number. (3) If an oral order is issued, a written order shall be issued as soon as is reasonably possible, but in no event later than 24 hours following the issuance of the oral order. (4) An individual or group subject to an oral order of isolation or quarantine may appeal the order by following the procedures specified in 105 CMR 300.210(F). (E) Further Requirements. (1) Contents of Written or Oral Order. The written or oral order of isolation or quarantine shall include the following. (a) The identity of the individual or description of the group of individuals subject to isolation or quarantine; (b) The date and time at which isolation or quarantine will commence and the duration of the isolation or quarantine period; (c) The reason for which isolation or quarantine is being ordered; (d) The place of isolation or quarantine; (e) Any special instructions or precautions that should be taken; (f) The legal authority under which the order is issued; and (g) A statement advising the individual or group that the order may be appealed by contacting a designated health official at a telephone number stated in the order. (2) If an individual or group is isolated or quarantined in a location other than their residences, the Department or local board of health must obtain an order of the Superior Court authorizing the isolation or quarantine as soon as practicable, but in no event later than ten days following the commencement of isolation or quarantine (F) Appeal of Written or Oral Order. (1) An individual or group subject to an order of isolation or quarantine may appeal the order by contacting a specified health official at a telephone number stated on the written order or provided orally at the time that the oral order is issued.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.210 continued

300.210: continued (2) An individual or group subject to an order of isolation or quarantine may file a petition in Superior Court challenging the order at any time. (3) Unless rescinded by order of the Department or local board of health or a court, the order for isolation or quarantine shall remain in force and effect until any appeal is finally determined. (G) Enforcement of Written or Oral Order. (1) The Department or local board of health shall take all reasonable measures to minimize the risk of exposure to disease of police officers and others assisting with enforcement of an isolation or quarantine order. (2) If an order for isolation or quarantine is violated, the Department or local board of health may apply to a judge of the Superior Court for an order to enforce the isolation or quarantine in a manner that will protect the public health. (H) Requirements for Isolation or Quarantine. (1) The Department or local board of health shall ensure that the following requirements are met, whether an individual or group is isolated or quarantined in their residences or in a place other than their residences. (a) The health status of isolated or quarantined individuals shall be monitored regularly to determine if they require continued isolation or quarantine. (b) The needs of individuals isolated or quarantined shall be addressed in a systematic and competent fashion, including, but not limited to, providing adequate food, medication, competent medical care, and crisis counseling or other mental health services when needed. (c) To the extent possible, cultural and religious beliefs and existing disabilities shall be considered in addressing the needs of individuals. (2) The Department or local board of health shall ensure that the following requirements are met when an individual or group is isolated or quarantined in a place other than their residences. (a) Isolated individuals shall be confined separately from quarantined individuals. (b) If a quarantined individual subsequently acquires or is reasonably believed to have acquired a disease or condition for which isolation is necessary to protect the public health, he or she shall promptly be removed to isolation. (c) Individuals isolated or quarantined shall be provided adequate clothing, food, shelter, and means of communication with persons outside isolation or quarantine. (d) Premises used for isolation and quarantine shall be maintained in a safe and hygienic manner and shall be designed to minimize the likelihood of further transmission of infection or other harms to individuals isolated and quarantined. (e) The Department or local board of health may authorize physicians, health care workers, mental health workers, personal care attendants, parents or guardians of minor children, and others access to individuals in isolation or quarantine as necessary to meet the needs of isolated or quarantined individuals. Individuals who use service animals shall be allowed to bring them into the isolation or quarantine premises. (f) No individual other than an authorized individual shall enter isolation or quarantine premises. Any individual entering isolation or quarantine premises with or without authorization may be isolated or quarantined. (I) Isolation or Quarantine of People in a Geographical Area. (1) The Department or local board of health may order the isolation or quarantine of all people in a geographical area that poses a serious danger to public health, when such isolation or quarantine is reasonably believed to be necessary to prevent the immediate spread of a dangerous disease to people outside the area. Such isolation or quarantine shall be implemented by means of a written order as provided in 105 CMR 300.210(C). (2) The Department or local board of health shall use all reasonable means of communica- tion to inform individuals in the area of orders and instructions in effect during the period of isolation or quarantine of people in the area. At a minimum, such communication shall include posting notices in places where people in and approaching the area are reasonably likely to see them, and publishing a notice in a newspaper of general circulation in the area at least once each week during the isolation or quarantine period, which notices shall state the orders and instructions in force with a brief explanation of their meaning and effect.

105 CMR: DEPARTMENT OF PUBLIC HEALTH

300.210 continued

300.210: continued (3) The Department or local board of health shall terminate the isolation or quarantine of all people in an area when the area no longer poses a serious danger to public health. (4) Any individual in the area subject to an order of isolation or quarantine may appeal the order as provided in 105 CMR 300.210(F). REGULATORY AUTHORITY 105 CMR 300.000:M.G.L. c. 111, §§ 1, 3, 5, 6, 7, 94C, 109, 110, 110B, 111 and 112, and c. 111D, § 6.